LivaNova PLC logo

LivaNova PLC (LIVN)

Market Closed
3 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
71. 33
-2
-2.73%
$
4.05B Market Cap
164.88 P/E Ratio
- Div Yield
709,611 Volume
3 Eps
$ 73.33
Previous Close
Add Transaction
Day Range
71 73.37
Year Range
41.01 75.81
Want to track LIVN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
LivaNova (LIVN) Upgraded to Buy: Here's What You Should Know

LivaNova (LIVN) Upgraded to Buy: Here's What You Should Know

LivaNova (LIVN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks | 3 weeks ago
LivaNova PLC (LIVN) Q1 2026 Earnings Call Transcript

LivaNova PLC (LIVN) Q1 2026 Earnings Call Transcript

LivaNova PLC (LIVN) Q1 2026 Earnings Call Transcript

Seekingalpha | 4 weeks ago
LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates

LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates

LivaNova (LIVN) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.85 per share. This compares to earnings of $0.88 per share a year ago.

Zacks | 4 weeks ago
LivaNova Expands OSA Care With FDA-Approved aura6000 System

LivaNova Expands OSA Care With FDA-Approved aura6000 System

LIVN wins FDA nod for its aura6000 sleep apnea system, marking a pivotal step in neurostimulation with strong trial results and new growth potential.

Zacks | 2 months ago
Down 7.2% in 4 Weeks, Here's Why You Should You Buy the Dip in LivaNova (LIVN)

Down 7.2% in 4 Weeks, Here's Why You Should You Buy the Dip in LivaNova (LIVN)

The heavy selling pressure might have exhausted for LivaNova (LIVN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Zacks | 2 months ago
All You Need to Know About LivaNova (LIVN) Rating Upgrade to Buy

All You Need to Know About LivaNova (LIVN) Rating Upgrade to Buy

LivaNova (LIVN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks | 3 months ago
LivaNova PLC (LIVN) Q4 2025 Earnings Call Transcript

LivaNova PLC (LIVN) Q4 2025 Earnings Call Transcript

LivaNova PLC (LIVN) Q4 2025 Earnings Call Transcript

Seekingalpha | 3 months ago
LivaNova (LIVN) Reports Q4 Earnings: What Key Metrics Have to Say

LivaNova (LIVN) Reports Q4 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for LivaNova (LIVN) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 3 months ago
LivaNova (LIVN) Tops Q4 Earnings and Revenue Estimates

LivaNova (LIVN) Tops Q4 Earnings and Revenue Estimates

LivaNova (LIVN) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.8 per share. This compares to earnings of $0.81 per share a year ago.

Zacks | 3 months ago
LivaNova PLC (LIVN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

LivaNova PLC (LIVN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

LivaNova PLC (LIVN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Seekingalpha | 4 months ago
LivaNova (LIVN) Tops Q3 Earnings and Revenue Estimates

LivaNova (LIVN) Tops Q3 Earnings and Revenue Estimates

LivaNova (LIVN) came out with quarterly earnings of $1.11 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $0.9 per share a year ago.

Zacks | 7 months ago
Is LivaNova (LIVN) Stock Undervalued Right Now?

Is LivaNova (LIVN) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 7 months ago
Loading...
Load More